Publicly Supported Partnerships Commit to Supporting Genomic Medicine for Economic Prosperity
Driven by large-scale efforts like the U.S. government-funded Human Genome Project, genomic medicine has gone from an aspirational term only 10 years ago to a rapidly growing, cutting-edge industry that is starting to produce economic benefits for regions, both domestically and abroad. To benefit from this rapidly growing trend, policymakers in New York and Canada recently announced significant funding to support genomic medicine initiatives.